logo
Breadcrumbs Image

Nuclear Drug for Therapeutic Market

Nuclear Drug for Therapeutic Market

Global Nuclear Drug for Therapeutic Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: Apr-2021 | Id: MACRC-66520 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Nuclear Drug for Therapeutic market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Rresearch newly published report.
 The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
 
 By Market Verdors:
 Bayer
 Novartis
 China Isotope & Radiation
 Dongcheng
 Q BioMed
 Curium Pharmaceuticals
 Jubilant DraxImage
 Lantheus
 Spectrum Pharmaceuticals
 Progenics Pharmaceuticals
 International Isotopes
 
 By Types:
 Radium-223
 Lutetium-177
 Iodine-131
 Other
 
 By Applications:
 Thyroid
 Bone Metastasis
 Lymphoma
 Other
 
 Key Indicators Analysed
 Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
 Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
 Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
 Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
 Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
 
 Key Reasons to Purchase
 To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
 Assess the production processes, major issues, and solutions to mitigate the development risk.
 To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 Learn about the market strategies that are being adopted by leading respective organizations.
 To understand the future outlook and prospects for the market.
 Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
 1.1 Study Scope and Definition
 1.2 Research Methodology
 1.2.1 Methodology/Research Approach
 1.2.2 Data Source
 1.3 Key Market Segments
 1.4 Players Covered: Ranking by Nuclear Drug for Therapeutic Revenue
 1.5 Market Analysis by Type
 1.5.1 Global Nuclear Drug for Therapeutic Market Size Growth Rate by Type: 2021 VS 2027
 1.5.2 Radium-223
 1.5.3 Lutetium-177
 1.5.4 Iodine-131
 1.5.5 Other
 1.6 Market by Application
 1.6.1 Global Nuclear Drug for Therapeutic Market Share by Application: 2022-2027
 1.6.2 Thyroid
 1.6.3 Bone Metastasis
 1.6.4 Lymphoma
 1.6.5 Other
 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
 1.7.2 Covid-19 Impact: Commodity Prices Indices
 1.7.3 Covid-19 Impact: Global Major Government Policy
 1.8 Study Objectives
 1.9 Years Considered
 2 Global Nuclear Drug for Therapeutic Market Trends and Growth Strategy
 2.1 Market Top Trends
 2.2 Market Drivers
 2.3 Market Challenges
 2.4 Porter’s Five Forces Analysis
 2.5 Market Growth Strategy
 2.6 SWOT Analysis
 3 Global Nuclear Drug for Therapeutic Market Players Profiles
 3.1 Bayer
 3.1.1 Bayer Company Profile
 3.1.2 Bayer Nuclear Drug for Therapeutic Product Specification
 3.1.3 Bayer Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.2 Novartis
 3.2.1 Novartis Company Profile
 3.2.2 Novartis Nuclear Drug for Therapeutic Product Specification
 3.2.3 Novartis Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.3 China Isotope & Radiation
 3.3.1 China Isotope & Radiation Company Profile
 3.3.2 China Isotope & Radiation Nuclear Drug for Therapeutic Product Specification
 3.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.4 Dongcheng
 3.4.1 Dongcheng Company Profile
 3.4.2 Dongcheng Nuclear Drug for Therapeutic Product Specification
 3.4.3 Dongcheng Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.5 Q BioMed
 3.5.1 Q BioMed Company Profile
 3.5.2 Q BioMed Nuclear Drug for Therapeutic Product Specification
 3.5.3 Q BioMed Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.6 Curium Pharmaceuticals
 3.6.1 Curium Pharmaceuticals Company Profile
 3.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Specification
 3.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.7 Jubilant DraxImage
 3.7.1 Jubilant DraxImage Company Profile
 3.7.2 Jubilant DraxImage Nuclear Drug for Therapeutic Product Specification
 3.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.8 Lantheus
 3.8.1 Lantheus Company Profile
 3.8.2 Lantheus Nuclear Drug for Therapeutic Product Specification
 3.8.3 Lantheus Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.9 Spectrum Pharmaceuticals
 3.9.1 Spectrum Pharmaceuticals Company Profile
 3.9.2 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Specification
 3.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.10 Progenics Pharmaceuticals
 3.10.1 Progenics Pharmaceuticals Company Profile
 3.10.2 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Specification
 3.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.11 International Isotopes
 3.11.1 International Isotopes Company Profile
 3.11.2 International Isotopes Nuclear Drug for Therapeutic Product Specification
 3.11.3 International Isotopes Nuclear Drug for Therapeutic Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 4 Global Nuclear Drug for Therapeutic Market Competition by Market Players
 4.1 Global Nuclear Drug for Therapeutic Production Capacity Market Share by Market Players (2016-2021)
 4.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Market Players (2016-2021)
 4.3 Global Nuclear Drug for Therapeutic Average Price by Market Players (2016-2021)
 5 Global Nuclear Drug for Therapeutic Production by Regions (2016-2021)
 5.1 North America
 5.1.1 North America Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.1.2 Nuclear Drug for Therapeutic Key Players in North America (2016-2021)
 5.1.3 North America Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.1.4 North America Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.2 East Asia
 5.2.1 East Asia Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.2.2 Nuclear Drug for Therapeutic Key Players in East Asia (2016-2021)
 5.2.3 East Asia Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.2.4 East Asia Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.3 Europe
 5.3.1 Europe Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.3.2 Nuclear Drug for Therapeutic Key Players in Europe (2016-2021)
 5.3.3 Europe Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.3.4 Europe Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.4 South Asia
 5.4.1 South Asia Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.4.2 Nuclear Drug for Therapeutic Key Players in South Asia (2016-2021)
 5.4.3 South Asia Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.4.4 South Asia Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.5 Southeast Asia
 5.5.1 Southeast Asia Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.5.2 Nuclear Drug for Therapeutic Key Players in Southeast Asia (2016-2021)
 5.5.3 Southeast Asia Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.5.4 Southeast Asia Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.6 Middle East
 5.6.1 Middle East Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.6.2 Nuclear Drug for Therapeutic Key Players in Middle East (2016-2021)
 5.6.3 Middle East Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.6.4 Middle East Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.7 Africa
 5.7.1 Africa Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.7.2 Nuclear Drug for Therapeutic Key Players in Africa (2016-2021)
 5.7.3 Africa Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.7.4 Africa Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.8 Oceania
 5.8.1 Oceania Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.8.2 Nuclear Drug for Therapeutic Key Players in Oceania (2016-2021)
 5.8.3 Oceania Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.8.4 Oceania Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.9 South America
 5.9.1 South America Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.9.2 Nuclear Drug for Therapeutic Key Players in South America (2016-2021)
 5.9.3 South America Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.9.4 South America Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 5.10 Rest of the World
 5.10.1 Rest of the World Nuclear Drug for Therapeutic Market Size (2016-2021)
 5.10.2 Nuclear Drug for Therapeutic Key Players in Rest of the World (2016-2021)
 5.10.3 Rest of the World Nuclear Drug for Therapeutic Market Size by Type (2016-2021)
 5.10.4 Rest of the World Nuclear Drug for Therapeutic Market Size by Application (2016-2021)
 6 Global Nuclear Drug for Therapeutic Consumption by Region (2016-2021)
 6.1 North America
 6.1.1 North America Nuclear Drug for Therapeutic Consumption by Countries
 6.1.2 United States
 6.1.3 Canada
 6.1.4 Mexico
 6.2 East Asia
 6.2.1 East Asia Nuclear Drug for Therapeutic Consumption by Countries
 6.2.2 China
 6.2.3 Japan
 6.2.4 South Korea
 6.3 Europe
 6.3.1 Europe Nuclear Drug for Therapeutic Consumption by Countries
 6.3.2 Germany
 6.3.3 United Kingdom
 6.3.4 France
 6.3.5 Italy
 6.3.6 Russia
 6.3.7 Spain
 6.3.8 Netherlands
 6.3.9 Switzerland
 6.3.10 Poland
 6.4 South Asia
 6.4.1 South Asia Nuclear Drug for Therapeutic Consumption by Countries
 6.4.2 India
 6.5 Southeast Asia
 6.5.1 Southeast Asia Nuclear Drug for Therapeutic Consumption by Countries
 6.5.2 Indonesia
 6.5.3 Thailand
 6.5.4 Singapore
 6.5.5 Malaysia
 6.5.6 Philippines
 6.6 Middle East
 6.6.1 Middle East Nuclear Drug for Therapeutic Consumption by Countries
 6.6.2 Turkey
 6.6.3 Saudi Arabia
 6.6.4 Iran
 6.6.5 United Arab Emirates
 6.7 Africa
 6.7.1 Africa Nuclear Drug for Therapeutic Consumption by Countries
 6.7.2 Nigeria
 6.7.3 South Africa
 6.8 Oceania
 6.8.1 Oceania Nuclear Drug for Therapeutic Consumption by Countries
 6.8.2 Australia
 6.9 South America
 6.9.1 South America Nuclear Drug for Therapeutic Consumption by Countries
 6.9.2 Brazil
 6.9.3 Argentina
 6.10 Rest of the World
 6.10.1 Rest of the World Nuclear Drug for Therapeutic Consumption by Countries
 7 Global Nuclear Drug for Therapeutic Production Forecast by Regions (2022-2027)
 7.1 Global Forecasted Production of Nuclear Drug for Therapeutic (2022-2027)
 7.2 Global Forecasted Revenue of Nuclear Drug for Therapeutic (2022-2027)
 7.3 Global Forecasted Price of Nuclear Drug for Therapeutic (2022-2027)
 7.4 Global Forecasted Production of Nuclear Drug for Therapeutic by Region (2022-2027)
 7.4.1 North America Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.2 East Asia Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.3 Europe Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.4 South Asia Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.5 Southeast Asia Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.6 Middle East Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.7 Africa Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.8 Oceania Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.9 South America Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.4.10 Rest of the World Nuclear Drug for Therapeutic Production, Revenue Forecast (2022-2027)
 7.5 Forecast by Type and by Application (2022-2027)
 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
 7.5.2 Global Forecasted Consumption of Nuclear Drug for Therapeutic by Application (2022-2027)
 8 Global Nuclear Drug for Therapeutic Consumption Forecast by Regions (2022-2027)
 8.1 North America Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.2 East Asia Market Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.3 Europe Market Forecasted Consumption of Nuclear Drug for Therapeutic by Countriy
 8.4 South Asia Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.5 Southeast Asia Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.6 Middle East Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.7 Africa Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.8 Oceania Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.9 South America Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 8.10 Rest of the world Forecasted Consumption of Nuclear Drug for Therapeutic by Country
 9 Global Nuclear Drug for Therapeutic Sales by Type (2016-2027)
 9.1 Global Nuclear Drug for Therapeutic Historic Market Size by Type (2016-2021)
 9.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Type (2022-2027)
 10 Global Nuclear Drug for Therapeutic Consumption by Application (2016-2027)
 10.1 Global Nuclear Drug for Therapeutic Historic Market Size by Application (2016-2021)
 10.2 Global Nuclear Drug for Therapeutic Forecasted Market Size by Application (2022-2027)
 11 Global Nuclear Drug for Therapeutic Manufacturing Cost Analysis
 11.1 Nuclear Drug for Therapeutic Key Raw Materials Analysis
 11.1.1 Key Raw Materials
 11.2 Proportion of Manufacturing Cost Structure
 11.3 Manufacturing Process Analysis of Nuclear Drug for Therapeutic
 12 Global Nuclear Drug for Therapeutic Marketing Channel, Distributors, Customers and Supply Chain
 12.1 Marketing Channel
 12.2 Nuclear Drug for Therapeutic Distributors List
 12.3 Nuclear Drug for Therapeutic Customers
 12.4 Nuclear Drug for Therapeutic Supply Chain Analysis
 13 Analyst's Viewpoints/Conclusions
 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00